Vaccine News and Research

Latest Vaccine News and Research

Malaria's characteristic cycle of fever and chills is a result of parasite's own influence

Scientists from the Walter Reed Army Institute of Research joined partners at Duke University, Florida Atlantic University and Montana State University to publish a study providing clear evidence that malaria's characteristic cycle of fever and chills is a result of the parasite's own influence--not factors from the host.

15 May 2020

A road map to find unanswered questions about COVID-19

There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.

15 May 2020

Continuously active antiviral coating may reduce the spread of COVID-19

Surfaces coated with a quaternary ammonium polymer have remarkable antiviral properties. They may even be capable of reducing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in areas with high risk for contamination, such as indoor environments or public places. University of Arizona researchers explain the antiviral potential of these in a new study published on the preprint server medRxiv.

14 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

14 May 2020

Low-cost PCR test designed to detect coronavirus

The project of Consuelo Rubio has been among those chosen for the call of the Valencian System of Innovation and Research for the COVID-19 emergency.

14 May 2020

Drug counterfeiters are using corona pandemic to make profits in Africa

Drug counterfeiters are using the corona pandemic to make profits in Africa selling completely ineffective or even harmful medicines.

14 May 2020

Cats can readily become infected with SARS-CoV-2, confirms study

In a study published today (May 13, 2020) in the New England Journal of Medicine, scientists in the U.S. and Japan report that in the laboratory, cats can readily become infected with SARS-CoV-2, the virus that causes COVID-19, and may be able to pass the virus to other cats.

14 May 2020

New map shows that distrust in health expertise could dominate online conversations

Communities on Facebook that distrust establishment health guidance are more effective than government health agencies and other reliable health groups at reaching and engaging "undecided" individuals, according to a study published today in the journal Nature.

14 May 2020

New combination offers complete protection against malaria

This ingredient is an essential component of the malaria parasite, a protein known as RPL6, which makes the parasite "visible" to a type of immune cells, the T cells, in the liver.

14 May 2020

Experts highlight triumph over polio and hope to do the same for COVID-19

For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching money was perilous.

14 May 2020

Relaxation of social and physical distancing measures may result in profound mortality

Even as the world struggles to live and make a living, faced with the dual threat of a rapidly spreading viral illness and economic slowdown, a new study published on the preprint server medRxiv in May 2020 says that relaxing non-pharmacological interventions will allow the SARS-CoV-2 virus to become endemic.

13 May 2020

COVID-19 lockdown exit strategies: deliverance or disaster?

A new study by researchers at the University of Cambridge, Universidad de Sevilla, and the University of Massachusetts, published on the preprint server medRxiv in May 2020, shows that it is essential to choose a restrictive exit strategy while easing COVID-19 lockdowns, because failure to do so may lead to catastrophic results.

13 May 2020

Researchers identify CoV Mac1 proteins as a potential SARS-CoV-2 drug target

A recent study by researchers at the University of Kansas and published on the preprint server bioRxiv* reveals that Mac1 protein implicated in the infection process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a strikingly similar structure and activity in all coronaviruses – suggesting that possible future treatments targeting this protein may exert broad antiviral activity.

13 May 2020

U of A researchers and Tonix Pharmaceuticals join forces to develop, test COVID-19 vaccine

University of Alberta researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to develop and test a vaccine against COVID-19.

13 May 2020

Vaccine design can face specific challenges, say researchers

The goal of a vaccine is to trigger a response that safely protects against an infection and/or the burden of disease.

13 May 2020

USP launches new program to accelerate the development of effective COVID-19 treatments

To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia has launched a new program to support scientists, developers and manufacturers worldwide.

13 May 2020

New method to control inflammatory response induced by COVID-19

Severe COVID-19 illness can result in excessive inflammation throughout the body, including the lungs, heart and brain. University of Minnesota Twin Cities student Molly Gilligan recently published an article in the journal Cancer & Metastasis Reviews that studied the human body's robust inflammatory response to the SARS-CoV-2 virus, which is now recognized as a hallmark symptom.

13 May 2020

Passive immummization can offer instant, short-term fortification against infectious agents

The worldwide COVID-19 pandemic has infected more than 4 million people and killed close to 280,000.1 Finding a vaccine has become a global public health priority.

13 May 2020

The ‘new normal’ in post-COVID-19 dental practice

A new paper published in the British Dental Journal in May 2020 reports on the new ways of partnership between the dental industry and dental professionals, in view of the extremely high risk of aerosol production during dental procedures, to reduce the risk of passing on COVID-19 infection.

13 May 2020

Vaccine News and Research

Latest Vaccine News and Research

Malaria's characteristic cycle of fever and chills is a result of parasite's own influence

A road map to find unanswered questions about COVID-19

Continuously active antiviral coating may reduce the spread of COVID-19

ACTG initiates clinical trial to evaluate treatment for COVID-19

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

Low-cost PCR test designed to detect coronavirus

Drug counterfeiters are using corona pandemic to make profits in Africa

Cats can readily become infected with SARS-CoV-2, confirms study

New map shows that distrust in health expertise could dominate online conversations

New combination offers complete protection against malaria

Experts highlight triumph over polio and hope to do the same for COVID-19

Relaxation of social and physical distancing measures may result in profound mortality

COVID-19 lockdown exit strategies: deliverance or disaster?

Researchers identify CoV Mac1 proteins as a potential SARS-CoV-2 drug target

U of A researchers and Tonix Pharmaceuticals join forces to develop, test COVID-19 vaccine

Vaccine design can face specific challenges, say researchers

USP launches new program to accelerate the development of effective COVID-19 treatments

New method to control inflammatory response induced by COVID-19

Passive immummization can offer instant, short-term fortification against infectious agents

The ‘new normal’ in post-COVID-19 dental practice

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in